Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM TrialMarcello Tiseo, Andrea Ardizzoni, Luca Boni et al.|Journal of Clinical Oncology|2017Cited by 186
Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future DevelopmentMarina Elena Cazzaniga, Guido Bocci, Andrea Camerini et al.|Future Oncology|2015Cited by 54
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving ImmunotherapyMaria Laura Canale, Nicola Maurea, Andrea Camerini et al.|Advances in Therapy|2020Cited by 43
Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM TrialMarcello Tiseo, Andrea Ardizzoni, Francesca Zanelli et al.|Clinical Lung Cancer|2014Cited by 19
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionalsIrma Bisceglia, Furio Colivicchi, Maria Laura Canale et al.|Frontiers in Cardiovascular Medicine|2023Cited by 17